SCHEMBL21940792

SCHEMBL21940792

Nc1cnc(OCC(F)F)c(Cl)c1

nearest known ligand 0.41

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 15/20 0.41
CYP3A4 P08684 2/20 0.33
CYP2C9 P11712 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C19 P33261 1/20 0.33
LMNA P02545 1/20 0.33
TSHR P16473 1/20 0.33
APEX1 P27695 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
SCN5A Q14524 5/20 0.32
HTR2A P28223 2/20 0.31
HTR2C P28335 2/20 0.31
HTR2B P41595 2/20 0.31
PDE8A O60658 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16175131 0.83 SCN9A (0.44) SCN9ACYP3A4CYP2C9LMNATSHR
SCHEMBL16858566 0.83 SCN9A (0.44) SCN9ACYP3A4CYP2C9SCN5A
SCHEMBL4550342 0.80 SCN9A (0.40) SCN9ACYP3A4CYP2C9SCN5AHTR2A
SCHEMBL17947491 0.79 SCN9A (0.39) SCN9ACYP3A4CYP2C9LMNATSHR
SCHEMBL15599216 0.79 SCN9A (0.44) SCN9ACYP3A4CYP2C9LMNATSHR
Hydrochloric Acid SCHEMBL2717080 0.79 SCN9A (0.39) SCN9ACYP3A4CYP2C9SCN5AHTR2A
SCHEMBL17292928 0.79 HCRTR1 (0.34) SCN9ACYP3A4CYP2C9CYP1A2CYP2C19
SCHEMBL4550399 0.78 SCN9A (0.39) SCN9ACYP3A4CYP2C9SCN5A
SCHEMBL2713741 0.77 SCN9A (0.40) SCN9ACYP3A4CYP2C9SMN1; SMN2SCN5A
SCHEMBL21940790 0.77 AAK1 (0.34) SCN9ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3423445-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS GALAPAGOS NV (BE) 2020-04-01 EP disclosed